Characterization of pharmacist-based medication management services in a community pharmacy |
| |
| Affiliation: | 1. Collaboration for Outcomes Research & Evaluation (CORE), University of British Columbia, Vancouver, BC, Canada;2. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada;3. School of Pharmacy, University of Otago, Dunedin, New Zealand;4. Centre for Health Evaluation and Outcome Sciences, Providence Health Research Institute, Vancouver, BC, Canada;1. Touro University California, Vallejo, CA, USA;2. Cedarville, University, Cedarville, OH, USA;3. Beirut Arab University, Beirut, Lebanon;4. University of Sydney, Sydney, Australia;5. National Institute for Health and Care Excellence, UK;6. Clinical Pharmacy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt;7. Texas A&M Health Sciences Center, College Station, TX, USA;8. University of Copenhagen, Copenhagen, Denmark;1. School of Pharmacy and Life Sciences, Robert Gordon University, Sir Ian Wood Building, Garthdee Road, Aberdeen, AB10 7GJ, United Kingdom;2. Pharmacy Department, Women''s Wellness and Research Center, Hamad Medical Corporation, PO Box 3050, Doha, Qatar;3. College of Pharmacy, Qatar University Health, Qatar University, P.O. Box 2713, Doha, Qatar;1. School of Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland;2. School of Social Policy, Social Work & Social Justice, University College Dublin, Dublin 4, Ireland;3. Public Policy Research Centre, Hokkaido University, Japan |
| |
| Abstract: | BackgroundMedication management (MM) refers to all clinical activities that a pharmacist performs to ensure safe and effective medication therapy for patients.ObjectiveTo characterize pharmacist-driven MM services via retrospective analysis of real-world data collected in a community pharmacy in British Columbia (BC), Canada.MethodsThis was a retrospective longitudinal study from January 2014–December 2015. Patient demographics, clinical problems, identified drug-related problems (DTPs), and pharmacists' interventions were summarized using descriptive statistics. The relationship between DTPs and the clinical conditions, as well as DTPs and the interventions, were analyzed. Other outcomes included: the relationship between patients’ age and visit time with the number of DTPs; the number of clinical conditions; and the number of interventions.Results1,572 patients received MM (mean visit time = 29.1 min). 2,133 DTPs were identified, which resulted in 7176 recommended interventions. The clinical problems most frequently encountered were cardiovascular (20%), and mental (15.7%). The most frequently identified DTP was “needs additional therapy” (61.8%), while the most frequently initiated or recommended interventions were education (43.4%), and changing therapy (21.6%). Elderly patients with multiple comorbidities had more DTPs and required more interventions and even when no DTPs were identified, some patients still received counselling and education in these visits.ConclusionUsing real-world data, this research demonstrated that patients benefit from identification and resolution of DTPs through pharmacists-driven MM programs. |
| |
| Keywords: | Medication management Drug therapy problem Pharmacist intervention |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
